RASSF1 and breast carcinoma: Kaplan–Meier curve analysis showed that neither DNMT1 nor RASSF1 high expression was significantly associated with OS or disease-specific survival in breast cancer patients (log-rank P > 0.05) (Fig. S4A–D).